Atrial Fibrillation Ablation Outcomes in GLP-1 Drug Users vs Non-Users
Comparison of AFib ablation outcomes in GLP-1 drug users versus non-users reveals whether these metabolic drugs affect arrhythmia recurrence after cardiac ablation.
Quick Facts
What This Study Found
Comparison of AFib ablation outcomes in GLP-1 drug users versus non-users reveals whether these metabolic drugs affect arrhythmia recurrence after cardiac ablation.
Key Numbers
US TriNetX database analysis from 2016-2022 comparing ablation outcomes between HFpEF and HFrEF patients.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Comparison of AFib ablation outcomes in GLP-1 drug users versus non-users reveals whether these meta
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Comparison of outcomes after ablation of atrial fibrillation in patients with heart failure with preserved versus reduced ejection fraction: a US retrospective cohort analysis.
- Published In:
- Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2025)
- Authors:
- Amin, Ahmed Mazen, Gadelmawla, Ahmed Farid(3), Najah, Qasi, Awashra, Ameer, Abdelsayed, Kerollos, Abdelazeem, Basel, Felpel, Kevin, Kaplan, Rachel M, Winterfield, Jeffrey
- Database ID:
- RPEP-09926
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Comparison of AFib ablation outcomes in GLP-1 drug users versus non-users reveals whether these metabolic drugs affect arrhythmia recurrence after cardiac ablation.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09926APA
Amin, Ahmed Mazen; Gadelmawla, Ahmed Farid; Najah, Qasi; Awashra, Ameer; Abdelsayed, Kerollos; Abdelazeem, Basel; Felpel, Kevin; Kaplan, Rachel M; Winterfield, Jeffrey. (2025). Comparison of outcomes after ablation of atrial fibrillation in patients with heart failure with preserved versus reduced ejection fraction: a US retrospective cohort analysis.. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. https://doi.org/10.1007/s10840-025-02197-3
MLA
Amin, Ahmed Mazen, et al. "Comparison of outcomes after ablation of atrial fibrillation in patients with heart failure with preserved versus reduced ejection fraction: a US retrospective cohort analysis.." Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2025. https://doi.org/10.1007/s10840-025-02197-3
RethinkPeptides
RethinkPeptides Research Database. "Comparison of outcomes after ablation of atrial fibrillation..." RPEP-09926. Retrieved from https://rethinkpeptides.com/research/amin-2025-comparison-of-outcomes-after
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.